Crohn's Disease + Ulcerative Colitis Research

New treatments for inflammatory bowel diseases (IBD) cannot be developed without the help of clinical trial participants, also known as volunteers. Through clinical research we are finding out if investigational medicines (medicines being studied) may help people with conditions including:

  • Crohn’s Disease
  • Ulcerative Colitis

By taking part in a clinical research study, you can help to make a difference. Click here to view Crohn’s disease and ulcerative colitis trials.

Person sitting down and smiling widely at the camera.

About Our Research

If you are thinking about participating in a clinical trial, you might have a lot of questions. In this section, we give you information about diverse representation in clinical trials and how participant wellbeing is protected. We also give you some information about what to expect before, during and after a trial. This information and talking to your doctor, research team and loved ones, may help you decide if a clinical research study is the right path for you. You can visit our Clinical Trial Information page for more information.

What to Expect

Inflammatory Bowel Disease Research Areas

Inflammatory bowel diseases (IBD) can impact people of all ages and from all countries. Both Crohn’s disease and ulcerative colitis are types of IBD. Which type of IBD you are diagnosed with depends on the:

  • location,
  • type of inflammation, and,
  • depth of inflammation in the lining of the digestive tract.

Crohn’s disease and ulcerative colitis can be difficult to manage and may impact quality of life. People may experience flares, where their IBD gets worse, and remission, where they do not experience symptoms. With clinical research, we are looking for more convenient and effective ways to manage IBD, and potentially prevent flares (when symptoms get worse) or shorten their duration. We are also looking for ways to prevent long-term complications. Below you can find more information about Crohn’s disease and ulcerative colitis. Here you can view Crohn’s disease and ulcerative colitis clinical trials.

Graphic of 3 puzzle pieces.

Lilly Trial Connect

Answer a few questions using Lilly Trial Connect to find which Lilly trials may be the best fit for you or your loved one.

Answer a few questions using Lilly Trial Connect to find which Lilly trials may be the best fit for you or your loved one.

Find a Trial

Conditions: Ulcerative Colitis
Trial Name
LUCENT 3
Drugs: Mirikizumab
Age
18 - 80 years
Phase
III
Conditions: Ulcerative Colitis
Trial Name
SHINE-2
Drugs: LY3074828
Age
2 - 17 years
Phase
III
Conditions: Ulcerative Colitis
Trial Name
LUCENT-URGE
Drugs: Mirikizumab
Age
≥18 years
Phase
III
Conditions: Crohn's Disease
Trial Name
VIVID-2
Drugs: Mirikizumab
Age
≥18 years
Phase
III
Conditions: Crohn's Disease
Trial Name
SHINE-ON
Drugs: Mirikizumab
Age
2 - 19 years
Phase
III

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.

Not the right fit? Sign up to receive Lilly Trial Alerts to find out about new trials.

Learning Center